Reconciling the discrepancies on the involvement of large-conductance Ca2+-activated K+ channels in glioblastoma cell migration

Autor: Luigi eCatacuzzeno, Martino eCaramia, Luigi eSforna, Silvia eBelia, Luca eGuglielmi, Maria Cristina D'Adamo, Mauro ePessia, Fabio eFranciolini

Publikováno v: Frontiers in Cellular Neuroscience, Vol 9 (2015)

Glioblastoma is the most common and aggressive primary brain tumor, and is notable for spreading so effectively through the brain parenchyma to make complete surgical resection virtually impossible, and prospect of life dismal. Several ion channels h

Externí odkaz: https://doaj.org/article/98159cc16ce14817b3bdd0bd614fa72e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.

Autor: Nardone V; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy., Botta C; c Medical Oncology Unit, Department of Clinical and Experimental Medicine , 'Magna Graecia' University of Catanzaro , Catanzaro , Italy., Caraglia M; d Department of Biochemistry , Biophysics and General Pathology, Second University of Naples , Naples , Italy., Martino EC; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy., Ambrosio MR; e Section of Pathology, Department of Medical Biotechnology , University of Siena , Siena , Italy., Carfagno T; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy., Tini P; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy., Semeraro L; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy., Misso G; d Department of Biochemistry , Biophysics and General Pathology, Second University of Naples , Naples , Italy., Grimaldi A; d Department of Biochemistry , Biophysics and General Pathology, Second University of Naples , Naples , Italy., Boccellino M; d Department of Biochemistry , Biophysics and General Pathology, Second University of Naples , Naples , Italy., Facchini G; f Urogynechological Department , INT Fondazione 'G. Pascale ' Naples , Italy., Berretta M; g Department of Medical Oncology , National Cancer Institute , Aviano (PN ) Italy., Vischi G; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy., Rocca BJ; e Section of Pathology, Department of Medical Biotechnology , University of Siena , Siena , Italy.; h Pathology Unit , Ospedale di Circolo di Busto Arsizio (VA) Italy., Barone A; e Section of Pathology, Department of Medical Biotechnology , University of Siena , Siena , Italy., Tassone P; c Medical Oncology Unit, Department of Clinical and Experimental Medicine , 'Magna Graecia' University of Catanzaro , Catanzaro , Italy., Tagliaferri P; c Medical Oncology Unit, Department of Clinical and Experimental Medicine , 'Magna Graecia' University of Catanzaro , Catanzaro , Italy., Del Vecchio MT; e Section of Pathology, Department of Medical Biotechnology , University of Siena , Siena , Italy., Pirtoli L; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy., Correale P; a Radiotherapy Unit, Department of Oncology , Siena University School of Medicine , Italy.; b Tuscany Tumor Institute (ITT) , Firenze , Italy.

Publikováno v: Cancer biology & therapy [Cancer Biol Ther] 2016 Nov; Vol. 17 (11), pp. 1213-1220.

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response.

Autor: Botta C; Department of Clinical and Experimental Medicine, Magna Graecia University, Catanzaro, Italy., Misso G; Department of Biochemistry, Biophysics and General Pathology, Second Naples University, Naples, Italy., Martino EC; Department of Oncology, Siena, Italy., Pirtoli L; Department of Oncology, Siena, Italy., Cusi MG; Department of Medical Biotechnology University of Siena, Siena, Italy., Tassone P; Department of Clinical and Experimental Medicine, Magna Graecia University, Catanzaro, Italy., Tagliaferri P; Department of Clinical and Experimental Medicine, Magna Graecia University, Catanzaro, Italy., Caraglia M; Department of Biochemistry, Biophysics and General Pathology, Second Naples University, Naples, Italy., Correale P; Department of Oncology, Siena, Italy.

Publikováno v: Cell death & disease [Cell Death Dis] 2016 Jul 21; Vol. 7, pp. e2299. Date of Electronic Publication: 2016 Jul 21.

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients.

Autor: Cusi MG; Department of Medical Biotechnologies, Siena University, Siena, Italy., Botta C, Pastina P, Rossetti MG, Dreassi E, Guidelli GM, Fioravanti A, Martino EC, Gandolfo C, Pagliuchi M, Basile A, Carbone SF, Ricci V, Micheli L, Tassone P, Tagliaferri P, Pirtoli L, Correale P

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2015 Sep; Vol. 64 (9), pp. 1159-73. Date of Electronic Publication: 2015 Jun 02.